MOG and myeloid sarcoma: As a disease model, we used the myelin oligodendrocyte glycoprotein (MOG)-EAE-mouse model for MS, an inflammatory disease with neurodegenerative components and clinical manifestations of motor deficits, which can be monitored daily.